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ABSTRACT 
Objective: To characterize the status of cardiometabolic risk factors after late relapse of type 2 
diabetes mellitus (T2DM) and to identify factors predicting relapse after initial diabetes 
remission following bariatric surgery to construct prediction models for clinical practice. 
Research design and methods: Outcomes of 736 patients with T2DM who underwent Roux-
en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) at an academic center (2004–2012) 
and had ≥5 years’ glycemic follow-up were assessed. Of 736 patients, 425 (58%) experienced 
diabetes remission (HbA1c <6.5% [48 mmol/mol] with patients off medications) in the 1st year 
after surgery. These 425 patients were followed for a median of 8 years (range 5–14) to 
characterize late relapse of diabetes. Results: In 136 (32%) patients who experienced late 
relapse, a statistically significant improvement in glycemic control, number of diabetes 
medications including insulin use, blood pressure, and lipid profile was still observed at long-
term. Independent baseline predictors of late relapse were preoperative number of diabetes 
medications, duration of T2DM before surgery, and SG versus RYGB. Furthermore, patients 
who relapsed lost less weight during the 1st year after surgery and regained more weight 
afterward. Prediction models were constructed and externally validated. Conclusions: While 
late relapse of T2DM is a real phenomenon (one-third of our cohort), it should not be 
considered a failure, as the trajectory of the disease and its related cardiometabolic risk factors 
is changed favorably after bariatric surgery. Earlier surgical intervention, RYGB (compared 
with SG) and more weight loss (less late weight regain) are associated with less diabetes relapse 
in the long-term. 
